Abstract:The prevalence of Crohn's disease (CD), a subtype of inflammatory bowel disease (IBD), is increasing worldwide. The pathogenesis of CD is hypothesized to be related to environmental, genetic, immunological, and bacterial factors. Current studies have indicated that intestinal epithelial cells, including columnar, Paneth, M, tuft, and goblet cells dysfunctions, are strongly associated with these pathogenic factors. In particular, goblet cells dysfunctions have been shown to be related to CD pathogenesis by direct or indirect ways, according to the emerging studies. The mucus barrier was established with the help of mucins secreted by goblet cells. Not only do the mucins mediate the mucus barrier permeability and bacterium selection, but also, they are closely linked with the endothelial reticulum stress during the synthesis process. Goblet cells also play a vital role in immune response. It was indicated that goblet cells take part in the antigen presentation and cytokines secretion process. Disrupted goblet cells related immune process were widely discovered in CD patients. Meanwhile, dysbiosis of commensal and pathogenic microbiota can induce myriad immune responses through mucus and goblet cell-associated antigen passage. Microbiome dysbiosis lead to inflammatory reaction against pathogenic bacteria and abnormal tolerogenic response. All these three pathways, including the loss of mucus barrier function, abnormal immune reaction, and microbiome dysbiosis, may have independent or cooperative effect on the CD pathogenesis. However, many of the specific mechanisms underlying these pathways remain unclear. Based on the current understandings of goblet cell's role in CD pathogenesis, substances including butyrate, PPARγagonist, Farnesoid X receptor agonist, nuclear factor-Kappa B, nitrate, cytokines mediators, dietary and nutrient therapies were all found to have potential therapeutic effects on CD by regulating the goblet cells mediated pathways. Several monoclonal antibodies already in use for the treatment of CD in the clinical settings were also found to have some goblet cells related therapeutic targets. In this review, we introduce the disease-related functions of goblet cells, their relationship with CD, their possible mechanisms, and current CD treatments targeting goblet cells.

The role of neutrophils in the pathogenesis of Crohn's disease

Neutrophils in chronic inflammatory diseases

The Dual Role of Neutrophils in Inflammatory Bowel Diseases

Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD)

Pathogens in Crohn's Disease: The Role of Adherent Invasive Escherichia coli

Crohn's Disease: Loss of Tolerance or a Disorder of Autophagy?

Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease

Dichotomous roles of neutrophils in modulating pathogenic and repair processes of inflammatory bowel diseases

The role of neutrophils during intestinal inflammation

Neutrophils: from IBD to the gut microbiota

Autophagy in Crohn's Disease: Converging on Dysfunctional Innate Immunity

The role of goblet cells in Crohn' s disease

Inflammatory Complications in Chronic Granulomatous Disease

Neutrophil Extracellular Traps in Inflammatory Bowel Disease: Pathogenic Mechanisms and Clinical Translation

Defective macrophage handling of Escherichia coli in Crohn's disease

Dual role of CD177 + neutrophils in inflammatory bowel disease: a review

NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis

S2766 A Rare Case of Chronic Granulomatous Disease in a Patient With Crohn's Disease

The Roles and Functions of Paneth Cells in Crohn’s Disease: A Critical Review

Functional neutrophil disorders: Chronic granulomatous disease and beyond

High Levels of IL-18 and IFN-γ in Chronically Inflamed Tissue in Chronic Granulomatous Disease